BEYOND AIR INC. - COMMON STOCK

Beyond Air® Schedules Second Fiscal Quarter 2023 Financial Results Conference Call and Webcast

20 Oct 2022 16:05:00 By Nasdaq GlobeNewswire

Beyond Air® Announces Positive Data from At-Home Pilot Study in Patients with Refractory NTM Lung Infection Treated with (NO) using the LungFit® GO at the CHEST Annual Meeting 2022

17 Oct 2022 16:05:00 By Nasdaq GlobeNewswire

Beyond Cancer™ to Present Pre-Clinical Data for Ultra-High Concentration Nitric Oxide Therapy at the 2022 SITC Annual Meeting

05 Oct 2022 08:00:01 By Nasdaq GlobeNewswire

Beyond Air® Announces that Annals of the American Thoracic Society Published a Review of the Third Pilot Study of High Dose Nitric Oxide for Bronchiolitis

03 Oct 2022 07:30:00 By Nasdaq GlobeNewswire

Beyond Air® To Participate in Three Upcoming Investor Conferences

16 Sep 2022 16:05:00 By Nasdaq GlobeNewswire

Beyond Air® Affiliate Beyond Cancer™ Doses Initial Patient in First-in-Human Phase 1 Study of Ultra-High Concentration Nitric Oxide Therapy at Tel Aviv Sourasky Medical Center (Ichilov)

23 Aug 2022 08:00:01 By Nasdaq GlobeNewswire

Beyond Air® Reports Financial Results for the First Quarter of Fiscal Year 2023

11 Aug 2022 16:05:02 By Nasdaq GlobeNewswire

Beyond Air® Schedules First Fiscal Quarter 2023 Financial Results Conference Call and Webcast

27 Jul 2022 16:05:01 By Nasdaq GlobeNewswire

Beyond Air® Reports Financial Results for Fourth Fiscal Quarter and Year-End 2022

28 Jun 2022 16:10:00 By Nasdaq GlobeNewswire

Beyond Air’s LungFit® PH Receives FDA Approval to Treat Term and Near-Term Neonates with Hypoxic Respiratory Failure

28 Jun 2022 16:05:00 By Nasdaq GlobeNewswire

Beyond Air® Announces Fiscal Year End 2022 Financial Results Conference Call and Webcast Moved to Tuesday, June 28th

14 Jun 2022 16:30:00 By Nasdaq GlobeNewswire

Beyond Cancer™ Announces the Appointment of Jedidiah Monson, M.D. to Chief Medical Officer

01 Jun 2022 07:00:01 By Nasdaq GlobeNewswire

Beyond Air® Presents Positive Study Update from the At-Home LungFit® GO Pilot Study for Nontuberculous Mycobacterial Lung Disease at the American Thoracic Society International Conference 2022

17 May 2022 16:05:00 By Nasdaq GlobeNewswire

Beyond Cancer, Ltd. Appoints Susan Howell Jones, CPA as Chief Financial Officer

17 May 2022 07:00:02 By Nasdaq GlobeNewswire

Beyond Air® Schedules Fiscal Year 2022 Financial Results Conference Call and Webcast

16 May 2022 07:05:00 By Nasdaq GlobeNewswire

Beyond Air® Reports Positive Long-Term Safety Data for High Concentration Inhaled Nitric Oxide in Bronchiolitis at the Pediatric Academic Societies Meeting 2022

25 Apr 2022 16:05:00 By Nasdaq GlobeNewswire

Beyond Air® Presents Positive Safety and Efficacy Data for Inhaled Nitric Oxide to Treat COVID-19 at ECCMID 2022

25 Apr 2022 07:00:01 By Nasdaq GlobeNewswire

Beyond Air® to Participate in Three Upcoming Medical Conferences

18 Apr 2022 07:00:00 By Nasdaq GlobeNewswire

Beyond Cancer™ Announces New Preclinical Data Presented at American Association for Cancer Research (AACR) Showing Ultra-High Concentration Nitric Oxide Therapy Anti-Tumor Effect

11 Apr 2022 07:00:00 By Nasdaq GlobeNewswire

Beyond Cancer™ to Present Two Abstracts for Ultra-High Concentration Nitric Oxide Therapy at the 2022 AACR Annual Meeting

08 Mar 2022 16:35:00 By Nasdaq GlobeNewswire